Sandoz Group AG
F:D8Y0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sandoz Group AG
F:D8Y0
|
CH |
|
W
|
Wartsila Oyj Abp
XMUN:MTA
|
FI |
|
M
|
Matsui Securities Co Ltd
DUS:MTW
|
JP |
|
E
|
Eqva ASA
OSE:EQVA
|
NO |
|
E
|
ECA Integrated Solution Bhd
KLSE:ECA
|
MY |
Intrinsic Value
Is D8Y0 undervalued or overvalued?
See the intrinsic value estimate for Sandoz Group AG and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
D8Y0 looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with D8Y0’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Sandoz Group Does
Sandoz Group AG makes generic medicines and biosimilars, which are lower-cost versions of brand-name drugs and complex biologic medicines after patents expire. It also supplies certain established medicines such as antibiotics and other hospital and retail pharmacy products. The company sells to wholesalers, pharmacies, hospitals, and health systems that need reliable access to medicines at lower prices.
- Headquarters
- Switzerland CH
- Employees
- 22 356
- IPO date
- Oct 4, 2023
Latest Earnings Call
- Stock, day of the call
- −2.2%
Earnings Waterfall
Sandoz Group AG
The intrinsic value for Sandoz Group AG (D8Y0) under the Base Case is hidden EUR.
Compared with the current market price of 82.5 EUR, the stock appears hidden.